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The nonstructural protein-2 (NS2) of canine parvovirus (CPV) is produced from the left-hand open reading frame of the viral
genome and contains 87 amino-terminal amino acids in common with nonstructural protein 1 (NS1) joined to 78 amino acids
from an alternative open reading frame. In the minute virus of mice parvovirus NS2 plays a role in controlling capsid protein
assembly and translation in a host-specific manner. The predicted NS2 of CPV is divergent from the proteins of the rodent
parvoviruses, and the protein and its functions have not been described. We characterized the large and the small splices
of CPV using reverse transcriptase–PCR. NS2 was identified using anti-peptide antibodies against the predicted C-terminal
sequence and also by expressing the protein from a plasmid vector. The protein could be detected at low levels in the nucleus
and the cytoplasm of a proportion of CPV-infected cells, as well as in cells transfected with the expression plasmid. Virus
genomes were prepared with mutations in the splice donor or acceptor sites of the NS2-specific intron or with three different
termination codons in the NS2-unique exon. Both splice donor and acceptor mutations resulted in the use of previously
cryptic splice sites, and the virus containing the splice donor mutation replicated inefficiently. However, the other four mutant
viruses were all viable and replicated efficiently in cat and dog cells, and two mutant viruses that were tested appeared to
assemble their capsids in the same manner as did the wildtype. After inoculation of dogs an NS2 mutant virus with a
termination codon in the NS2-unique exon replicated to titers similar to those seen for wildtype CPV in several tissues
examined. © 1998 Academic Press
INTRODUCTION
Canine parvovirus (CPV) is a member of the feline
parvovirus subgroup of the autonomous parvoviruses
(Murphy et al., 1995; Parrish, 1990). The autonomous
parvoviruses that are similar to minute virus of mice
(MVM) all appear to contain genes for two nonstructural
(NS) proteins, NS1 and NS2, as well as two viral struc-
tural proteins, VP1 and VP2 (Cotmore et al., 1983; Cot-
more and Tattersall, 1986, 1987). The structural (VP1 and
VP2) and nonstructural proteins are transcribed from
separate promoters at about 38 and 4 genome map units
(m.u.), respectively (reviewed Cotmore and Tattersall,
1987). The different proteins are derived by alternative
splicing of the RNA transcripts and in MVM most tran-
scripts terminate at a single polyadenylation sequence
(Clemens and Pintel, 1987).
NS2 is formed from a spliced message (R2) tran-
scribed from the P4 promoter, which in the prototype
strain of MVM (MVMp) joins 85 N-terminal residues from
reading frame 3 to between 97 and 103 residues from
reading frame 2 (Cotmore et al., 1983; Cotmore and
Tattersall, 1986; Morgan and Ward, 1986). In MVM 3
different carboxy termini may be present in NS2 depend-
ing on the splicing of a small intron linking the first two
exons to one or other additional exon sequences (Cot-
more and Tattersall, 1990; Morgan and Ward, 1986). Pro-
duction of the correct proportions of R1 and R2 mRNAs is
subject to a variety of controls, which affect the splicing
from suboptimal sequences in the R2 splice donor, and
splicing also depends on translation of the small exon in
the R2 message (Zhao et al., 1995a,b, 1994). Mutants of
MVM with splice acceptor or termination mutations in
NS2 replicate very poorly in murine cells, although they
replicate more efficiently in cells from other hosts (Cater
and Pintel, 1992). In murine cells deletion or truncation of
NS2 affects efficient capsid protein assembly and
causes a decrease in translation of viral mRNA, and the
mutant viruses replicate to very low levels in mice
(Brownstein et al., 1992; Cotmore et al., 1997; Naeger et
al., 1990, 1993). In MVM phosphorylated forms of NS2 are
found preferentially in the cytoplasm (Cotmore and Tat-
tersall, 1990), and they also associate with the b and z
isoforms of the 14-3-3 class of cellular proteins from a
variety of hosts, through interaction with phosphoserine
interactions (Brockhaus et al., 1996). NS2 functions of the
rat parvovirus H1 virus appear similar in many features to
those of MVM. The protein is required for efficient repli-
cation and virion production in rat cells and to cause
disease in rats, but it is not required for the virus to cause
disease in hamsters or for replication in human cells.
The host-specific effect appears to be on the efficiency of
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translation of the capsid proteins, mediated through se-
quences in the 39-nontranslated regions of the viral mes-
sages (Li and Rhode, 1991, 1993).
Less is known about the NS2 proteins of the parvovi-
ruses other than MVM and H1. Candidate NS2 proteins
have been immunoprecipitated from cells infected with
LuIII, bovine parvovirus, and rabbit parvovirus (Cotmore
and Tattersall, 1986; Matsunaga and Matsuno, 1983), but
in one study no NS2-like protein was immunoprecipi-
tated by an antiserum against the MVM protein se-
quences from the in vitro translation products of mRNA
from CPV-infected cells (Cotmore and Tattersall, 1986).
The host ranges of CPV and FPV are complex, and
differ both in vitro and in vivo, and they depend on both
the host animal and the differentiated state of the cell
(Truyen et al., 1996; Truyen and Parrish, 1992). CPV in-
fection of dog cells or dogs is controlled primarily by the
capsid protein gene, with two or three residues which
differ between CPV and FPV being particularly important
(Chang et al., 1992; Horiuchi et al., 1994; Llamas-Saiz et
al., 1996). Those residues are found in three regions of
the surface of the capsid and result in a variety of
structural differences that can be identified by X-ray
crystallography (Agbandje et al., 1993; Llamas-Saiz et al.,
1996). The replication of two variants of MVM (MVMi and
MVMp) in lymphocytes or fibroblasts is also controlled
by small numbers of sequence differences within the
capsid protein gene (Ball-Goodrich and Tattersall, 1992;
Gardiner and Tattersall, 1988).
As well as the major host range determinants within
the capsid protein gene, less pronounced effects have
been mapped to the NS1 and NS2 gene regions of CPV
and MVM. In studies of recombinants between CPV and
mink enteritis virus (MEV), sequence differences be-
tween 22 and 45 m.u. in the genome were shown to
affect infection or replication in canine cells, although the
precise changes involved were not determined (Horiuchi
et al., 1994). The replication of pig parvovirus (PPV) in
canine cells is controlled by sequences in both the
structural proteins and the NS1 gene region of the ge-
nome (Vasudevacharya and Compans, 1992). For MVMp
and MVMi recombinants, viruses containing certain
combinations of sequences from the NS1 gene region
differed in efficiency of cell infection and plaquing
(Gardiner and Tattersall, 1988).
Here we have defined the nature of the splicing of the
large and small introns of CPV and shown that NS2 is
indeed produced by that virus. We examined the func-
tions of NS2 by introducing mutations into an infectious
clone which were predicted to alter the NS2 expression
or size. The mutations had no consistent effect on in vitro
infection, replication, or capsid assembly in a variety of
cells. One mutant virus with a termination codon in NS2
replicated in dogs as well as its wildtype parent.
RESULTS
Splicing
Splicing of the CPV mRNA transcripts was examined by
RT–PCR and sequencing. As shown in Fig. 1, the small
splice joined alternative donors at nt 2280 (2273GGA-
TTAAG1GTACG) or nt 2316 (2311GGAGAG1GTAAG) to a
single splice acceptor at nt 2389 (2384TATAG2GACTTG) in
the sequence of CPV-d (Parrish, 1991). The R2 splice which
would form NS2 joins the 59 exon by the nonconsensus
splice donor at nt 532 (528AAAAA1GCAAGT) to a consen-
sus splice acceptor at nt 2005 (2001CCAG2GTTGCA). All R2
transcripts cloned were also spliced at the small intron, as
would be expected for the model of parvovirus alternative
splicing regulation (Zhao et al., 1995a,b, 1994). In CPV the
NS2 open reading frame terminated prior to the small in-
tron, which is in contrast to the situation in the rodent
parvoviruses. The 87-residue amino-terminal domain of
NS2 shared with NS1 was quite conserved between CPV
and the rodent parvoviruses (MVM, H1, MPV) (55% identity
between CPV and MVMp), as well as the PPV (Fig. 3). The
NS2 carboxy-terminal domain was very conserved among
the rodent parvoviruses (100% identity between MVMp and
MPV; 76% identity between MVM and H1), but in CPV that
sequence was divergent both from the rodent viruses (30%
identity with MVM) and PPV (20% identity) (Fig. 3). The NS1
sequence encoded within the alternative reading frame
from the NS2 C-terminal domain was more highly con-
served (52% identity between CPV and MVM).
NS2 protein expression
The NS2 protein was readily demonstrated in CPV-d-
infected A72 cells by immunofluorescence, although it
was not detected at the same levels in all cells which
expressed capsid proteins (Figs. 2A and 2B). The pro-
tein was detected throughout the cell, with increased
amounts in the nuclei of some cells. Fluorescent anti-
body staining of infected synchronized cells indicated
that neither the level of NS2 expression nor cell localiza-
tion was significantly affected by the stage of the cell
cycle (results not shown). NS2 protein expressed from a
mammalian plasmid expression vector showed a similar
distribution within the cells as was seen in the infected
cells, but the level of expression was similar in all NS2-
positive cells (Fig. 2D).
NS2-related proteins were immune precipitated from
[35S]methionine-labeled cells which were infected with
CPV-d or transfected with the NS2 gene in a plasmid
expression vector (Fig. 4). The protein from the infected
cells was present as a single band of 19 kDa, which was
the size predicted from the DNA sequence of the gene.
After plasmid expression the full-length native NS2 pro-
tein was formed, as well as a form about 2000 Da smaller
which may represent a product that is less phosphory-
lated (Clemens et al., 1990) (Fig. 4).
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NS2 mutant viruses
Mutations were prepared which introduced termination
codons at various positions in the NS2-specific portion of
the open reading frame or which were designed to inacti-
vate the R2 splice donor or acceptor (Fig. 1). All five mutants
would likely produce some amount of the NS2 amino-
terminal domain, as RT–PCR of mRNA from cells inoculated
with mutant G533A (R2 splice donor) or mutant A2003T (R2
splice acceptor) showed that some mRNA was spliced
using previously cryptic splice donor and acceptor sites,
respectively (Fig. 1). After transfection of NLFK or A72 cells
the G533A infectious plasmid replicated very inefficiently,
but it did form low levels of viral DNA and virus.
To verify the presence of the NS2 mutants, the accu-
mulations of NS2 and capsid proteins were examined by
immunoprecipitation of infected A72 cells labeled for 3 h
with [35S]methionine (Fig. 5). With the exception of
G533A, the NS2 mutants all produced amounts of VP1
and VP2 approximately equal to those produced by
CPV-d. The NS2 protein could be precipitated from the
CPV-d-infected but not from the mutant infected cells,
confirming that intact NS2 protein was not expressed by
the mutant viruses.
Forty-eight hours after transfection of wildtype or mu-
tant infectious plasmids, four of the mutants produced
similar amounts of capsids or virions in HA, ELISA, and
TCID50 assays, and similar amounts of RF-DNA were
recovered from cells transfected with those plasmids
(Fig. 6A). Although the G533A plasmid was viable and
infectious virus was recovered after transfection, the
production of capsid protein was less than 1/10 that of
the other mutants examined (Fig. 5B). We do not have an
explanation for that difference, but it may be related to
the alternative splicing of that sequence once the R2
splice donor was mutated. There were no additional
mutations in G533A that would explain the differences in
infectivity or replication, as the region containing the
mutation was recloned into a new infectious plasmid
background, the region replaced was sequenced, and
the virus derived had the same properties as G533A.
When viruses were prepared from transfection of A72
cells and used to inoculate A72 or NLFK cells, the four
mutants besides G533A all produced both double- and
single- stranded DNA at levels similar to those of CPV-d in
A72 cells. In NLFK cells the DNA levels of the mutant
viruses were consistently slightly lower than those in
CPV-d, but again they produced both the double- and sin-
gle-stranded DNA forms in similar proportions (Fig. 6B).
NS2 mutants of MVM appear to assemble poorly in
cells (Cotmore et al., 1997). The assembly of mutants
FIG. 1. (A) Genetic structure of the left-hand 60% of the CPV genome, showing the P4 and P38 promoters, the locations of the splice sites in the
R2 and R3 mRNAs, and open reading frames of NS1 and NS2. (B) Mutations prepared in these studies. The mutations are identified by the wildtype
nucleotide, the nucleotide number, and the new nucleotide in the mutant. The wildtype and mutated virus sequences and the NS1 and NS2
translations are also shown. The normal R2 splice donor and acceptor sequences identified in these studies are indicated, as is the alternative donor
used in the mutant virus G533A.
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A2003T and A2033T in A72 cells was therefore com-
pared to that in CPV-d by [35S]methionine labeling for 30
min and then incubation of the cells with complete me-
dium for 2 h. Capsid formation was analyzed by sucrose
gradient centrifugation, and similar levels of empty and
full capsids were seen for the three viruses (Fig. 7).
Inoculation of feline CRFK and 3201 cells, or canine
A72 and MDCK cells, showed only small differences
among CPV-d, A2003T, and A2033T in the levels of virus
recovered (Fig. 8). None of the viruses infected COS-1,
NB324K, or L cells.
Mutant A2033T replicated efficiently in dogs, with ti-
ters that were similar to or higher than those seen for
CPV-d in several tissues examined (Fig. 9).
FIG. 2. Identification of the NS2 protein in infected cells and expression from a plasmid vector. (A) CPV-d-infected A72 cells stained with mouse
anti-NS2 peptide serum and detected with FITC-labeled anti-mouse IgG. (B) The same cells as in (A) stained with RITC-conjugated rabbit anti-capsid
antibodies. (C) Expression vector for transient expression of NS2. The plasmid was prepared in the pCEP4 vector and contains a complete cDNA copy
of the NS2 message, as well as the CMV immediate early promoter and the SV40 polyadenylation signal. (D) A72 cells 48 h after transfection with
the NS2 plasmid, stained with mouse anti-NS2 peptide serum, and detected with FITC-labeled anti-mouse IgG.
FIG. 3. Alignment of the translated CPV-d NS2 sequence with those of H1, MVMp, mouse parvovirus (MPV), and PPV. Shading indicates that the
sequence is identical between CPV and the other virus. The MVM, H1, and MPV sequences all terminate after the small intron in the sequence and
hence have at least three alternative NS2 carboxy-terminal sequences, two of which are introduced by alternative splicing. For H1, MPV, and MVM
the most common ‘‘P’’ isoform is shown (Cotmore and Tattersall, 1990).
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DISCUSSION
Here we show that the predicted NS2 protein gene of
CPV is functional and that a single NS2 protein is pro-
duced in virus-infected cells. The size of the protein was
close to the 19,076 predicted from the translated DNA
sequence. Five mutants of CPV were prepared, and all
were viable. Analysis of the effects of altering the splice
donor or acceptor sequences was complicated by the
fact that in each case an alternative sequence used to
splice the message was detected by RT–PCR. Analysis
of four of the five mutants which would affect NS2 tran-
scription or translation showed that intact NS2 was not
required for efficient virus DNA replication or single-
stranded DNA production. When two mutants (A2003T
and A2033T) were examined for capsid assembly in the
A72 cells they assembled in a fashion similar to that of
wildtype virus. One other mutation (G533A) which altered
the R2 splice donor sequence resulted in inefficient DNA
replication after plasmid transfection, and the virus grew
to only low titers. Although we cannot explain why that
virus replicates poorly by comparison with the other
mutants, recloning of the mutation showed that the effect
seen was due to the mutation introduced, and it is pos-
sible that this was related to the use of an alternative
splice acceptor that alters the regulation of RNA tran-
scription or splicing.
The role of the NS2 in in vivo infection was examined
by inoculation of dogs with one of the mutants (A2033T)
which contained a termination mutation in the second
NS2 exon, close to the splice acceptor. That virus grew
efficiently in several tissues of the dogs (Fig. 9), indicat-
ing that the intact NS2 was also not required for efficient
replication in vivo in the host from which the virus was
isolated. There are a number of possible explanations for
this apparent lack of effect of the four NS2 mutations.
Read through of the termination codon does not occur at
levels where the protein can be detected in the RIP
assay (Fig. 5A). A truncated form of NS2, containing only
the amino-terminal domain, may provide NS2 functions,
although that is unlikely based on similar studies of MVM
NS2 (Brownstein et al., 1992; Cater and Pintel, 1992;
Cotmore et al., 1997; Naeger et al., 1990). A further
possibility is that the dogs or the cat, mink, or dog cells
tested here may not represent the original host of the
CPV. Perhaps there is another (as yet unidentified) host
from which CPV originally derived, in which NS2 is re-
quired for efficient replication. This would be similar to
the situation reported for H1, where NS2 is required for
the virus to replicate and cause disease in vivo in rats but
not in hamsters (Li and Rhode, 1991).
The function(s) of NS2 in the replication of autono-
mous parvoviruses are still poorly understood. Most
studies have been conducted on MVM and H1 parvovi-
ruses, where NS2 mutations result in the viruses repli-
cating poorly in their normal host cells, although they
replicate with greater but variable efficiency in cells from
other hosts (Brownstein et al., 1992; Cater and Pintel,
1992; Li and Rhode 1991; Naeger et al., 1990). The NS2
proteins of the rodent parvoviruses are highly conserved
in sequence (Fig. 3), with 97% identity in NS2 sequence
between MVM and MPV, indicating that there is a strong
sequence dependence for their function(s) in rodents.
NS2 mutants in MVM rapidly revert to wildtype sequence
or acquire compensating mutations (Cotmore et al.,
1997), further indicating that the NS2 protein plays an
important role in efficient replication of that virus. The
cell restriction for MVM or H1 NS2 mutants appears to be
due to an inefficient assembly of VP1 and VP2 into
capsids in mouse or rat cells, with apparently a subse-
quent decreased translation of the capsid proteins (Cot-
more et al., 1997; Li and Rhode, 1991).
The finding that the NS2 of MVM and H1 was required
FIG. 5. Immune precipitation of [35S]methionine-labeled proteins
from mock-infected A72 cells or from A72 cells inoculated with 105
TCID50 of CPV-d or each of the five different mutant viruses. (A) Cell
lysates precipitated with the mouse anti-NS2 peptide serum. (B) Pro-
teins from the same cells immune precipitated with a rabbit anti-capsid
serum.
FIG. 4. Immune precipitation of proteins from [35S]methionine-la-
beled cells using a mouse anti-NS2 peptide serum. A72 or NLFK cells
were mock infected, infected with CPV-d, or transfected with the plas-
mid expressing NS2.
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for replication in the cells and tissues of the normal host
animal also indicates that NS2 plays a role in controlling
the viral host range. Major determinants of host range of
CPV, MEV, MVM, or PPV have all been mapped to spe-
cific sequences within the capsid protein genes (Ball-
Goodrich and Tattersall, 1992; Bergeron et al., 1996;
Chang et al., 1992; Horiuchi et al., 1994; Vasudevacharya
and Compans, 1992). However, determinants which en-
hance growth in certain host cells have also been
mapped to the NS1 or NS2 genes of those viruses
(Gardiner and Tattersall, 1988; Horiuchi et al., 1994; Va-
sudevacharya and Compans, 1992). The finding that NS2
of MVM assists in capsid assembly in the homologous
host cell suggests that there could be an interaction
between the host range determining mutations of the
capsid protein gene and the NS2 sequence, at least in
the rodent parvoviruses.
Although the NS2 gene sequence is present as an
intact open reading frame in all CPV, FPV, and MEV
sequences that have been reported, and we show here
that it is expressed from CPV, it differs significantly in
amino acid sequence from the NS2 of the rodent viruses
and PPV. The NS2 open reading frame of CPV also
terminated prior to the small intron in the genome, so
FIG. 7. Assembly of the capsid proteins of (A) CPV-d, (B) A2003T, or (C) A2033T in virus-infected cells. A72 cells were incubated with viruses for
24 h, labeled for 30 min with [35S]methionine, and then incubated for 2 h with complete medium. Proteins were harvested and banded on 10–40%
sucrose gradients, and then virus was immunoprecipitated from gradient fractions using a rabbit anti-capsid antiserum and electrophoresed in
SDS–PAGE. The positions in the gradients of empty and full capsids are indicated.
FIG. 6. DNA replication of CPV-d or the NS2 mutants after inoculation or transfection of A72 or NLFK cells. DNA recovered using a modified
Hirt-extraction method was electrophoresed in a 1% agarose gel with 1 mg/ml of ethidium bromide, Southern blotted, and probed with a 32P-labeled
full-length viral DNA fragment. The dimer replicative form (dRF), monomer RF (mRF), and single-stranded (ss) DNAs are indicated. (A) DNAs recovered
after transfection of A72 cells with infectious plasmids. The DNA recovered was treated with DpnI prior to electrophoresis. The input DNA of each
plasmid added is represented by a DpnI fragment which is present in all the plasmids. (B) Viral DNAs recovered 48 h after inoculation of A72 or NLFK
cells with the various viruses.
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that the different isoforms of NS2 seen in MVM-infected
cells would not be formed (Fig. 1). Four mutations which
removed varying amounts of the carboxy-terminal do-
main of the protein did not affect the DNA replication of
CPV or its protein translation or capsid assembly and
also did not greatly affect the infection or replication of
the virus in tissue cultured cells or in dogs. This indi-
cates that the NS2 of CPV has properties different than
those of the rodent parvoviruses and that its functions for
the virus life style or replication must be relatively subtle.
MATERIALS AND METHODS
Viruses and cells
The CPV-d strain of CPV type-2 was derived from an
infectious plasmid clone and propagated in Norden lab-
oratory ‘‘feline’’ kidney (NLFK) or A72 canine cells (Binn et
al., 1980; Parrish, 1991). The NLFK cells in our laboratory
are the most susceptible cells for infection and growth of
all the carnivore parvoviruses we have tested to date, but
recent genetic analyses indicate that these NLFK cells
are not feline cells, but appear to be closely related to
mink lung cells (C. R. Parrish, unpublished results).
Other cells tested in these studies included CRFK
feline cells (Crandell et al., 1973), a 3201 feline thymoma-
derived cell line (Rojko et al., 1989), type I and type II
strains of the MDCK canine kidney cell line (Nichols et
al., 1986), human NB324K cells, African green monkey
COS cells, and mouse L cells. Cells were grown either in
a 50% mixture of McCoy’s 5A and Leibovitz L15 with 5%
fetal bovine serum (FBS) or in Dulbecco’s minimal es-
sential medium with 10% FBS.
Mutations of the CPV-d sequence were prepared to
alter the NS2-specific R2 splice donor or the R2 splice
acceptor or to introduce termination codons into the
second NS2 exon (Fig. 1). The NS1 polypeptide se-
quence was left unchanged, and the altered NS1 codons
were ones that were commonly used in the CPV NS1 and
VP gene sequences. Mutations were introduced using
specific oligonucleotide primers and uracil-containing
M13 DNA, as described by Kunkel (1985). The regions
containing the mutations were sequenced and intro-
duced back into the CPV-d infectious clone. Plasmids
were transfected into NLFK or A72 cells using Lipo-
fectamine (Gibco/BRL, Gaithersburg, MD), and viruses
recovered were passaged twice before being frozen as
stocks. Stock viruses were confirmed as being mutant by
PCR amplification and sequencing of the region contain-
ing the mutation. Mutant A2033T contained a unique new
NheI site (GCTAGC), and the presence of that mutation
was therefore also monitored by NheI digestion of RF-
DNA or PCR products.
Transcription analysis
RNA recovered from virus-infected cells was pre-
treated with RNase-free DNase (Promega, Madison, WI),
reverse transcribed, and then the cDNA amplified with
primers flanking the predicted large or small splices. The
small splice products digested with TaqI and HindIII
were cloned into the mp18 vector digested with AccI and
HindIII. RT–PCR products spanning the large splice were
recovered from agarose gels, incubated with DNA poly-
merase I (Klenow fragment) and dNTPs, and then ligated
into SmaI-digested pGEM3Z plasmid. Clones were
sequenced using the M13, T7, or SP6 primers and
the Sequenase method (Amersham, Arlington Height, IL).
The NS2 sequences predicted for CPV-d were compared
to those of MVMp, H1, LuIII, mouse parvovirus
(MPV), and PPV. Sequences obtained from GenBank
were aligned using the Clustal W program of DNAStar
(DNAStar Inc., Madison, WI).
FIG. 9. Virus titers in tissues of 12-week-old dogs 5 days after
inoculation with 105 TCID50 of either A2033T or CPV-d. Tissues sam-
pled were the thymus, spleen, ileum, and mesenteric lymph nodes, and
titers were determined in NLFK cells.
FIG. 8. Virus TCID50 titers in NLFK cells for viruses recovered from
cells inoculated with CPV-d, A2003T, and A2033T. Cells tested were
canine A72 and MDCK type I and type II cells and feline 3201 or CRFK
cells.
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Protein expression, antibodies, and immune staining
The spliced form of the R2 message was isolated from
a cloned RT–PCR product, and the intact NS2 open
reading frame was cloned into the eucaryotic expression
vector pCEP4 (Invitrogen, San Diego, CA), under the
control of the CMV promoter (Fig. 2C). That plasmid was
transfected into A72 cells using Lipofectamine. Antibod-
ies were prepared against a peptide containing the car-
boxy-terminal sequence of NS2 (NS2 residues 153 to
165). The peptide was conjugated to keyhole limpet he-
mocyanin and inoculated once into mice in Freund’s
complete adjuvant and then repeatedly in Freund’s in-
complete adjuvant. Virus-infected or plasmid-transfected
cells were fixed with 2% paraformaldehyde in PBS for 10
min, permeabilized with 0.1% Triton X-100 in PBS, and
incubated first with the mouse anti-peptide sera and then
with fluorescein isothiocyanate (FITC)-conjugated goat
anti-mouse IgG. In some cases the cells were costained
with rhodamine isothiocyanate (RITC)-conjugated rabbit
IgG prepared against purified CPV capsids.
Cells infected with CPV-d or with NS2 mutants were
labeled between 24 and 27 h postinfection with [35S]me-
thionine (Amersham) at 0.2 mCi/ml. The cells were lysed
into radioimmune precipitation (RIP) buffer (50 mM Tris z
HCl (pH 7.5), 1% Triton X-100, 150 mM NaCl, 1 mM DTT,
1 mM PMSF, 5 mg/ml leupeptin, 2 mg/ml aprotinin). The
lysate was incubated with the mouse anti-NS2 peptide
serum and then with Immunoprecipitin (Gibco/BRL). The
precipitates were washed three times with RIP buffer, the
Immunoprecipitin was pelleted and boiled in SDS-load-
ing buffer, and then the proteins were electrophoresed in
12% SDS–polyacrylamide gels, which were then dried
and exposed to X-ray film.
Virus replication
Viral DNA replication was monitored after virus infec-
tion or after transfection with infectious plasmid DNA.
CRFK or A72 cells seeded at 1 3 104/cm2 in 9-cm2 wells
were transfected with 5 mg of plasmid DNA using 8 ml of
Lipofectamine. DNA was recovered from the cells 72 h
after infection or transfection by proteinase K digestion
and then phenol and chloroform extraction. DNA sam-
ples from the plasmid transfected cells were incubated
for 3 h with 10 U of DpnI in 50 mM Tris z HCl (pH 8.0), 10
mM MgCl2, 0.21 M NaCl, and 1 mM dithiothreitol. DNA
was electrophoresed in 1% agarose gels containing 1
mg/ml of ethidium bromide, Southern blotted to nylon
membranes, and probed with 32P-labeled DNA contain-
ing the complete CPV genome.
Capsid production after plasmid transfection or virus
infection was measured by hemagglutination (HA).
TCID50 titers were determined in NLFK cells seeded in
96-well trays, where wells containing infected cells were
identified by immunohistochemical staining, and titers
calculated by the method of Reed and Muench (1938). To
determine the efficiency of capsid assembly, NLFK cells
inoculated with CPV-d, or mutants A2003T or A2033T,
were labeled after 24 h with [35S]methionine for 30 min.
After incubation with complete medium for a further 2 h
the cells were lysed into RIPA buffer, layered over 10–
40% sucrose gradients in 50 mM Tris z HCl (pH 8.0), 150
mM NaCl, 2 mM MgCl2, 1 mM EDTA buffer, and centri-
fuged at 100,000 g for 6.5 h at 4°C. Proteins were im-
mune precipitated from gradient fractions with polyclonal
rabbit anti-capsid antibodies which recognize both as-
sembled and nonassembled capsid proteins and elec-
trophoresed in 10% SDS–PAGE, and then the gels were
dried and exposed to X-ray film.
Host range
CPV-d or the various viable NS2 mutants were titrated
in NLFK cells, then inoculated at a virus/cell multiplicity
of infection of 1 into A72, CRFK, 3201, MDCK, NB324K,
COS, or L cells. TCID50 titers recovered from the cultures
after freezing and thawing were determined in NLFK
cells. To confirm that the mutations were still present
after replication, virus in the supernatant of infected cells
was used directly as a template in PCR reactions, am-
plifying the region containing the mutations. The PCR
products were then sequenced or, in the case of A2033T,
the mutation was confirmed by digestion with NheI.
Two pairs of 10-week-old specific-pathogen-free bea-
gle dogs were inoculated intramuscularly with 105
TCID50 of either CPV-d or the NS2 mutant A2033T. Five
days later the animals were euthanized and the virus
titers in the thymus, mesenteric lymph node, spleen, and
ileum determined by TCID50 assay in NLFK cells. The
mutant nature of the viruses recovered from the thymus
of the dogs was confirmed by PCR amplification of DNA
of virus recovered from the tissues and NheI digestion of
the product.
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